Smoking cessation in smokers who smoke menthol and non-menthol cigarettes

Addiction

Volumn 109, Issue 12, 2014, Pages 2107-2117

  Smith, Stevens S ^a   Fiore, Michael C ^a   Baker, Timothy B ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Clinical trial; Gender; Generalized estimating equations; Longitudinal; Menthol; Race ethnicity; Smoking cessation; Tobacco

Indexed keywords

AMFEBUTAMONE; MENTHOL; NICOTINE; NICOTINE GUM;

ADULT; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; COUNSELING; CUTANEOUS DRUG ADMINISTRATION; DOUBLE BLIND PROCEDURE; HISTORY; HUMAN; LONGITUDINAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; TOBACCO; TREATMENT FAILURE; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; BUPROPION; COMBINED MODALITY THERAPY; COUNSELING; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HISTORY, 15TH CENTURY; HUMANS; LONGITUDINAL STUDIES; MALE; MENTHOL; NICOTINE; SEX FACTORS; SMOKING CESSATION; TOBACCO PRODUCTS; TOBACCO USE CESSATION PRODUCTS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84920500500     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12661     Document Type: Article

References (32)

1. Centers for Disease Control and Prevention. Vital signs: current cigarette smoking among adults aged ≥18 years-United States, 2005-2010. Morb Mortal Wkly Rep 2011; 60: 1207-1212.
2. Jha P., Ramasundarahettige C., Landsman V., Rostrom B., Thun M., Anderson R. N. etal. 21st century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013; 368: 341-350.
3. Thun M. J., Carter B. D., Feskanich D., Freedman N. D., Prentice R., Lopez A. D. etal. 50-Year trends in smoking-related deaths in the United States. N Engl J Med 2013; 368: 361-374.
4. Substance Abuse and Mental Health Services Administration. The NSDUH Report: Use of Menthol Cigarettes. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2009.
5. Tobacco Products Scientific Advisory Committee. Menthol Cigarettes and Public Health: Review of the Scientific Evidence and Recommendations. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration; 2011.
6. Foulds J., Hooper M. W., Pletcher M. J., Okuyemi K. S. Do smokers of menthol cigarettes find it harder to quit smoking? Nicotine Tob Res 2010; 12: S102-109.
7. Hoffman A. C., Miceli D. Menthol cigarettes and smoking cessation behavior. Tob Induc Dis 2011; 9: S6.
8. Cropsey K. L., Weaver M. F., Eldridge G. D., Villalobos G. C., Best A. M., Stitzer M. L. Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners. Nicotine Tob Res 2009; 11: 690-697.
9. Fu S. S., Okuyemi K. S., Partin M. R., Ahluwalia J. S., Nelson D. B., Clothier B. A. etal. Menthol cigarettes and smoking cessation during an aided quit attempt. Nicotine Tob Res 2008; 10: 457-462.
10. Harris K. J., Okuyemi K. S., Catley D., Mayo M. S., Ge B., Ahluwalia J. S. Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion. Prev Med 2004; 38: 498-502.
11. Foulds J., Gandhi K. K., Steinberg M. B., Richardson D. L., Williams J. M., Burke M. V. etal. Factors associated with quitting smoking at a tobacco dependence treatment clinic. Am J Health Behav 2006; 30: 400-412.
12. Gandhi K. K., Foulds J., Steinberg M. B., Lu S. E., Williams J. M. Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. Int J Clin Pract 2009; 63: 360-367.
13. Okuyemi K. S., Faseru B., Sanderson Cox L., Bronars C. A., Ahluwalia J. S. Relationship between menthol cigarettes and smoking cessation among African American light smokers. Addiction 2007; 102: 1979-1986.
14. Okuyemi K. S., Ahluwalia J. S., Ebersole-Robinson M., Catley D., Mayo M. S., Resnicow K. Does menthol attenuate the effect of bupropion among African American smokers? Addiction 2003; 98: 1387-1393.
15. D'Silva J., Boyle R. G., Lien R., Rode P., Okuyemi K. S. Cessation outcomes among treatment-seeking menthol and nonmenthol smokers. Am J Prev Med 2012; 43: S242-S248.
16. Faseru B., Nollen N. L., Mayo M. S., Krebill R., Choi W. S., Benowitz N. L. etal. Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial. Addict Behav 2013; 38: 1796-1803.
17. Rojewski A. M., Toll B. A., O'Malley S. S. Menthol cigarette use predicts treatment outcomes of weight-concerned smokers. Nicotine Tob Res 2014; 16: 115-119.
18. Lee J.-H., Herzog T. A., Meade C. D., Webb M. S., Brandon T. H. The use of GEE for analyzing longitudinal binomial data: a primer using data from a tobacco intervention. Addict Behav 2007; 32: 187-193.
19. Piper M. E., Smith S. S., Schlam T. R., Fiore M. C., Jorenby D. E., Fraser D. etal. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry 2009; 66: 1253-1262.
20. Brigham J., Lessov-Schlaggar C. N., Javitz H. S., McElroy M., Krasnow R., Swan G. E. Reliability of adult retrospective recall of lifetime tobacco use. Nicotine Tob Res 2008; 10: 287-299.
21. Sobell L. C., Sobell M. B., Leo G. I., Cancilla A. Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict 1988; 83: 393-402.
22. Fitzmaurice G. M., Laird N. M., Ware J. H. Applied Longitudinal Analysis, 2nd edn. Hoboken, NJ: Wiley; 2011.
23. Hedeker D., Gibbons R. D. Longitudinal Data Analysis. New York: Wiley; 2006.
24. Hosmer D. W. Jr, Lemeshow S. A., Sturdivant R. X. Applied Logistic Regression, 3rd edn. Hoboken, NJ: Wiley; 2013.
25. Diggle P., Heagarty P., Liang K.-Y., Zeger S. Analysis of Longitudinal Data, 2nd edn. New York: Oxford University Press; 2002.
26. Lindsey J. K., Lambert P. On the appropriateness of marginal models for repeated measurements in clinical trials. Stat Med 1998; 17: 447-469.
27. Agresti A. Categorical Data Analysis, 2nd edn. New York: John Wiley & Sons, Inc.; 2002.
28. Bolt D. M., Piper M. E., McCarthy D. E., Japuntich S. J., Fiore M. C., Smith S. S. etal. The Wisconsin Predicting Patients' Relapse Questionnaire. Nicotine Tob Res 2009; 11: 481-492.
29. Heatherton T. F., Kozlowski L. T., Frecker R. C., Fagerstrom K. O. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86: 1119-1127.
30. Miller G. A., Chapman J. P. Misunderstanding analysis of covariance. J Abnorm Psychol 2001; 110: 40-48.
31. Stahre M., Okuyemi K. S., Joseph A. M., Fu S. S. Racial/ethnic differences in menthol cigarette smoking, population quit ratios and utilization of evidence-based tobacco cessation treatments. Addiction 2010; 105: 75-83.
32. Trinidad D. R., Perez-Stable E. J., Messer K., White M. M., Pierce J. P. Menthol cigarettes and smoking cessation among racial/ethnic groups in the United States. Addiction 2010; 105: 84-94.